Publicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (3)

2024

  1. Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure

    Frontiers in Oncology, Vol. 14

2019

  1. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673

2013

  1. Agonist antibodies to TNFR molecules that costimulate T and NK cells

    Clinical Cancer Research, Vol. 19, Núm. 5, pp. 1044-1053